Document is current

Any future updates will be listed below

Oral nanoparticles containing naringenin suppress atherosclerotic progression by targeting delivery to plaque macrophages

Crossref DOI link: https://doi.org/10.1007/s12274-022-4808-2

Published Online: 2022-09-08

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark